Curezone Pharma Private Limited
About Curezone Pharma Private Limited
Data last updated:
Curezone Pharma Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 November 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290HR2022PTC107861.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Kanta Devi and Nitu Gupta.
Its last annual general meeting (AGM) was held on 04 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Kamlesh Kumar Gupta Complex Nanhera Road Ambala Cantt, Haryana, India – 133004.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.38 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹9,596 (net margin -0.3%) and EBITDA of ₹459 (EBITDA margin 0%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Kamlesh Kumar Gupta Complex Nanhera Road Ambala Cantt, Haryana, India – 133004
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Curezone Pharma Private Limited
The main business activity of Curezone Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Curezone Pharma Private Limited FY 2025 filings available
Curezone Pharma Private Limited reported revenue of ₹33.38 Lakh (up 183% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Curezone Pharma Private Limited
Revenue rose 183% in the latest year. EBITDA rose 102% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Curezone Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹459 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹9,596 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Curezone Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0% | •••• | •••• |
| Net Profit Margin | -0.3% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curezone Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Curezone Pharma Private Limited
Curezone Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanta Devi | Director | 21 Nov 2022 | 3 Years 11 Months | Current |
| Nitu Gupta | Director | 21 Nov 2022 | 3 Years 11 Months | Current |
Peer Comparison of Curezone Pharma Private Limited
Curezone Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sonix Commercials Pvt Ltd | ₹33.39 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| Kalmont Technologies Pvt Ltd | ₹33.39 Lakh (FY 2023) | •••• | •••• | -29.0% | •••• | Kolkata, West Bengal, India |
| Aggarwal Agencies Private Limited | ₹33.38 Lakh (FY 2025) | •••• | •••• | -50.0% | •••• | Jammu, Jammu and Kashmir, India |
| Excel Scales Pvt.Ltd. | ₹33.38 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Telangana, India |
| Auxinic Health Care Private Limited | ₹33.38 Lakh (FY 2019) | •••• | •••• | -18.0% | •••• | Tisgaon, Maharashtra, India |
| Curezone Pharma Private Limited this company | ₹33.38 Lakh (FY 2025) | •••• | •••• | 183.0% | •••• | Ambala, Haryana, India |
| Bellis Biotech Private Limited | ₹33.37 Lakh (FY 2016) | •••• | •••• | -19.0% | •••• | Bengaluru, Karnataka, India |
| Klasmek Solutions Private Limited | ₹33.37 Lakh (FY 2024) | •••• | •••• | 22.0% | •••• | Nagpur, Maharashtra, India |
| Digitalservo Grid Power Private Limited | ₹33.36 Lakh (FY 2022) | •••• | •••• | 822.0% | •••• | Delhi, India |
| Tricon Spinners Pvt Ltd | ₹33.36 Lakh (FY 2019) | •••• | •••• | -13.0% | •••• | Amritsar, Punjab, India |
| Vepocera India Private Limited | ₹33.36 Lakh (FY 2021) | •••• | •••• | -62.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Curezone Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Curezone Pharma Private Limited
Curezone Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Curezone Pharma Private Limited
Employment history and EPFO contributions of people linked to Curezone Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Curezone Pharma Private Limited
Curezone Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Kanta Devi was appointed as Director on 21 Nov 2022.
Credit Ratings, Litigation & Regulatory Alerts for Curezone Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Curezone Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Curezone Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Curezone Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Curezone Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curezone Pharma Private Limited
Curezone Pharma is an active private limited company based in Ambala, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 November 2022 (4+ years old) and is registered under CIN U24290HR2022PTC107861.
Curezone Pharma reported revenue of ₹33.38 Lakh for FY 2025 (up 183% YoY).
Curezone Pharma has 2 current directors:
- Kanta Devi - Director
- Nitu Gupta - Director
Curezone Pharma reported a net loss of ₹9,596 (net margin -0.3%) and EBITDA of ₹459 (EBITDA margin 0%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Curezone Pharma is U24290HR2022PTC107861. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curezone Pharma was incorporated on 21 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Curezone Pharma by revenue are Sonix Commercials Pvt Ltd, Kalmont Technologies Pvt Ltd, Aggarwal Agencies Private Limited, Excel Scales Pvt.Ltd, Auxinic Health Care Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Kanta Devi was appointed as Director on 21 Nov 2022. Nitu Gupta was appointed as Director on 21 Nov 2022.
The registered office of Curezone Pharma is at CO Kamlesh Kumar Gupta Complex Nanhera Road Ambala Cantt, Haryana, India – 133004.
Curezone Pharma has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹4 Lakh.
Curezone Pharma operates in the chemicals industry, in the manufacturing segment.